Jupiter Life Line Hospitals shareholding pattern

JLHL

1212.3

19.70 (-1.60%)
Last updated on 20 Feb, 2026 | 15:29 IST
alert_iconwatchlist_icon
BUYSELL
Zero AMC

Free Demat with Zero AMC*

Open a Free Demat Account
+ Free 1st Year AMC

Jupiter Life Line Hospitals Shareholding Pattern

  • 2023-24
  • 2025-26
  • 2024-25
Total Promoters
Segment
Percent

Total Promoters

40.91%

Mutual Fund

12.68%

Insurance

0.9%

Foreign Institutional Investors

3.96%

Domestic Institutional Investors

0.36%

Retail

41.19%

Others

0%

Total Promoters
SEP '23
40.91%
DEC '23
40.91%

Summary

For Year 2025-26, Jupiter Life Line Hospitals reports the following shareholding: Total Promoters at 40.91%, Mutual Fund at 11.55%, Insurance at 2.3%, Foreign Institutional Investors at 8.48%, Domestic Institutional Investors at 0.16%, and Retail at 36.59%. This breakdown provides a quick snapshot of ownership distribution for Jupiter Life Line Hospitals in 2025-26.

Jupiter Life Line Hospitals FAQs

As of 02-2026, the promoter shareholding in Jupiter Life Line Hospitals stands at 40.91% of the company's total shares. Promoter shareholding represents the ownership stake held by the company's founding members, management, or controlling entities, having a significant influence on the company's strategic direction and operations.

The FII and DII shareholding of Jupiter Life Line Hospitals is 8.48% and 0.16% respectively.

The retail shareholding of the Jupiter Life Line Hospitals is 36.59%.

Changes in shareholding patterns of Jupiter Life Line Hospitals can result from stock market transactions, issuance of new shares, buybacks, mergers, acquisitions, or changes in promoter holdings.

Shareholding patterns of Jupiter Life Line Hospitals are updated quarterly as mandated by regulatory authorities and may also be disclosed during significant corporate events.

The latest shareholding pattern is available on stock exchanges (e.g., NSE, BSE) and the company's official website under investor relations.

Invest with Zero-Cost Demat Account

Zero AMC for First Year
Free Research Calls
₹ 0 Trade & Call Fee
Zero-Cost